Old Web
English
Sign In
Acemap
>
authorDetail
>
Rachel Cowen
Rachel Cowen
Newcastle University
Biology
Cancer research
Drug
PI3K/AKT/mTOR pathway
MAPK/ERK pathway
5
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Reflection : Putting social responsibility at the heart of the institution: The research experience and career development of early career researchers
2019
Rachel Cowen
Judith Gracey
Dee-Ann Johnson
Show All
Source
Cite
Save
Citations (0)
HIF-1[alpha] is a common downstream target of PI3K and MAPK/ERK signalling in thyroid carcinomas
2008
Kaye Williams
Rachel Cowen
Wasielewski Reinhard Von
Murat Uenalan
Julia Resch
Catharine M L West
Georg Brabant
Show All
Source
Cite
Save
Citations (0)
Hypoxia inducible factor (HIF-1α) in thyroid carcinoma cell lines
2007
Rachel Cowen
Kaye Williams
Catherine West
Julia Resch
Georg Brabant
Show All
Source
Cite
Save
Citations (0)
Contribution of HIF-1 and drug penetrance to hypoxia- mediated oxaliplatin resistance in colorectal cancer spheroids
2007
Molecular Cancer Therapeutics
Darren Roberts
Kaye Williams
Rachel Cowen
Michael J. Tilby
D Graham Pearson
Chris J. Ottley
Ian Stratford
Caroline Dive
Show All
Source
Cite
Save
Citations (0)
Symposium Report CANCER CHEMOTHERAPY AND DRUG METABOLISM
2005
David S. Riddick
Chunja Lee
Shairoz Ramji
Edwin C. Chinje
Rachel Cowen
Kaye Williams
Adam V. Patterson
Ian Stratford
Charles S. Morrow
Alan J. Townsend
Youssef Jounaidi
Chong-Sheng Chen
Ting Su
Hong Lu
Pamela S. Schwartz
David J. Waxman
Show All
Source
Cite
Save
Citations (0)
1